WO2017152343A1 - Dispositif de bioréacteur à perfusion à recirculation capable d'effectuer une perfusion à recirculation d'un échafaudage tridimensionnel - Google Patents

Dispositif de bioréacteur à perfusion à recirculation capable d'effectuer une perfusion à recirculation d'un échafaudage tridimensionnel Download PDF

Info

Publication number
WO2017152343A1
WO2017152343A1 PCT/CN2016/075779 CN2016075779W WO2017152343A1 WO 2017152343 A1 WO2017152343 A1 WO 2017152343A1 CN 2016075779 W CN2016075779 W CN 2016075779W WO 2017152343 A1 WO2017152343 A1 WO 2017152343A1
Authority
WO
WIPO (PCT)
Prior art keywords
reactor
bioreactor
perfusion
liquid
input end
Prior art date
Application number
PCT/CN2016/075779
Other languages
English (en)
Chinese (zh)
Inventor
李君�
李兰娟
周倩
Original Assignee
浙江大学
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 浙江大学 filed Critical 浙江大学
Publication of WO2017152343A1 publication Critical patent/WO2017152343A1/fr

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M1/00—Apparatus for enzymology or microbiology
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M1/00—Apparatus for enzymology or microbiology
    • C12M1/04—Apparatus for enzymology or microbiology with gas introduction means

Definitions

  • the invention belongs to the fields of clinical medicine, tissue engineering and regenerative medicine, in particular, is a new device capable of realizing continuous supply of oxygen and nutrients of seed cells in tissue engineering three-dimensional scaffold.
  • Tissue engineering is a combination of engineering and life science principles and methods. It conducts the most basic research on the relationship between mammalian tissue structure and function in both normal and pathological states, and develops biologically useful alternatives for repair.
  • the basic principle is: the normal tissue cells are adsorbed on the biocompatible biomaterial to form a complex. After a period of cultivation, the cells are expanded and the biomaterial is gradually degraded and absorbed, thereby forming a specific morphology, structure and function.
  • Corresponding tissues and organs achieve the purpose of promoting tissue regeneration, repairing wounds and reconstructing functions.
  • At the heart of tissue engineering is the creation of a three-dimensional complex of cells and biological materials.
  • tissue engineering As a carrier of tissue engineering, scaffolding is a key part of tissue engineering research. It not only provides a three-dimensional environment for cell growth and a place for metabolism, but also determines the shape and size of new tissue and organs. Among them, the decellularized scaffold has become a research hotspot in the field of tissue engineering because it retains the intact vascular network structure and extracellular matrix components.
  • tissue engineering technology and materials science some simple tissue organs, such as skin, blood vessels, bones, cartilage, etc., can be artificially constructed, bringing dawn to the treatment of organ transplant patients.
  • organ organizations with relatively complex structures and functions still face enormous challenges. Among them, the continuous and effective supply of cellular oxygen and nutrients in large three-dimensional scaffolds is a major problem. How to achieve long-term culture and functional maintenance of cells in three-dimensional scaffolds is our key consideration.
  • tissue engineering bioreactors provides technical support for the construction of tissue engineering organs.
  • the invention is based on the improvement of the existing circulating perfusion bioreactor, and provides a simple circulating perfusion device for culturing tissue engineering organs in vitro, and provides technical support for the research of stem cell differentiation and cell growth under three-dimensional conditions.
  • the invention aims at the problem that the cells in the tissue engineering three-dimensional scaffold can not survive for a long time due to insufficient supply of oxygen and nutrients, and the activity rate is low, and a cyclic perfusion bioreactor device is disclosed to provide continuous cells for the three-dimensional scaffold.
  • the supply of nutrients provides technical support for the study of stem cell differentiation and cell growth under three-dimensional conditions, overcomes the shortcomings of existing static culture, and constructs functional tissue engineering organs. Thereby, the long-term culture and function maintenance of the cells in the three-dimensional scaffold are realized, the tissue engineering organ is constructed, and the long-term culture of the recellularized scaffold in vitro is realized while ensuring the cell activity.
  • the invention discloses a circulating perfusion bioreactor device.
  • the device comprises a bioreactor and a perfusion device.
  • the perfusion device comprises a peristaltic pump and a pipeline system arranged on the peristaltic pump.
  • the bioreactor comprises a sterile culture chamber and a closed anastomosis cover.
  • the bioreactor can be connected with a three-dimensional scaffold to meet the required culture space of the three-dimensional scaffold, avoiding a large waste of the culture liquid, facilitating the operation of the three-dimensional scaffold in the sterile chamber, storing the culture medium in the sterile culture chamber, and placing the three-dimensional scaffold, and peristaltic
  • the pump can adjust the control by setting the perfusion mode, perfusion flow rate, irrigation flow rate, etc., to adapt to different research needs and organizational construction needs.
  • the bioreactor of the present invention has a liquid input end on the reactor, and a sealed inlet cap is provided with a liquid input end of the reactor and a gas inlet, and the liquid output end of the reactor is placed. Below the liquid level in a sterile culture chamber.
  • the pipeline system of the present invention is a silica gel tube-like structure comprising a silica gel inflow section and a silica gel outflow section, and the inlet end of the piping system on the silica inflow section is connected to the liquid output end of the reactor, and the silica gel is discharged from the section.
  • the outlet end of the piping system is connected to the liquid input end of the reactor.
  • a gas filter is connected to the gas inlet of the present invention.
  • the gas filter can ensure the sterilizing of oxygen, carbon dioxide and the like into the sterile culture chamber outside the reactor to ensure the sterility of the sterile culture chamber, and at the same time satisfy the sufficient gas supply of the culture liquid.
  • liquid input end of the reactor and the liquid output end of the reactor of the present invention are detachable and independent tubular structures.
  • the design avoids the over-tightness of the closed anastomosis cap and the good compatibility with the bioreactor, which ensures the tightness of the entire reactor system.
  • the closed anastomosis cover of the present invention and the sterile culture chamber body portion are provided as a matte. The sealing of the reactor unit is guaranteed.
  • the liquid input end of the reactor of the present invention is fine at both ends, and is respectively connected with a silicone tube and a trocar, and the intermediate diameter is increased to exhibit a drip-like structure, and the liquid input end of the reactor is It is at an angle of 70-80° to the side wall of the reactor.
  • the design allows the gas generated in the silicone pipe system to be above the liquid level in the input pipe, thereby effectively preventing air bubbles from entering the bracket in the silicone pipe system.
  • the inflow port of the three-dimensional support can be connected to the liquid input end on the side wall without causing the tear deformation of the support.
  • the bioreactor of the present invention is made of a transparent material or a disposable sterile material.
  • the transparent material is heat-resistant and high-temperature resistant, can withstand high-pressure steam sterilization of 120-200 degrees, realizes repeated use of the reactor device, and the transparent design of the container can be more conveniently observed.
  • the disposable sterile material is a transparent, non-toxic, stable and stable disposable material, which is convenient, high-efficiency, avoids cross-contamination, does not release toxic substances in the cell culture environment, affects cell growth, and the transparent design of the container It is also easy to observe.
  • the transparent material of the present invention is transparent borosilicate glass or quartz glass.
  • the piping system of the present invention is a high pressure steam sterilized silicone tube that can withstand 120-200 degrees.
  • the silicone tube is resistant to high temperatures and stable in performance.
  • the bioreactor sterile culture chamber culture liquid enters the closed pipeline system through the liquid output end of the reactor, and under the control of the peristaltic pump, flows into the three-dimensional stent through the liquid input end of the reactor, thereby realizing the culture liquid in Complete circulation in the entire three-dimensional scaffold provides effective nutrient supply, gas exchange, enhanced cell survival rate in the scaffold, and recellularization efficiency of the three-dimensional scaffold.
  • the pulsation stimulation of the peristaltic pump simulates blood flow in the body.
  • the gas inlet is arranged on the reactor, and a gas filter is arranged thereon to ensure that the oxygen, carbon dioxide and the like gas entering the sterile culture chamber outside the reactor are aseptic, so as to satisfy the sufficient gas supply of the culture liquid.
  • the liquid input end of the reactor draws on the design principle of the disposable infusion tube "Mofite dropper", and is designed to be small at both ends, which are respectively connected with the silicone tube and the trocar, and the intermediate diameter is increased to present a drip-like structure. .
  • the liquid input end is at an angle of 70-80° to the side wall of the reactor instead of entering vertically.
  • the gas generated in the silica gel pipe system is located above the liquid level in the input end tube, thereby effectively avoiding the silicone pipe. Air bubbles in the system enter the bracket.
  • the design allows the three-dimensional support to be connected to the liquid input end of the side wall without causing the tensile deformation of the support.
  • the whole perfusion system is simple and easy to operate.
  • the culture fluid perfusion in the stent can be controlled by adjusting and setting the perfusion mode, perfusion flow rate, perfusion pressure on the peristaltic pump.
  • Figure 1 is a schematic diagram showing the principle structure of an extracorporeal circulation perfusion bioreactor device
  • 1 is a bioreactor
  • 2 is a perfusion device
  • 3 is a sterile culture chamber
  • 4 is a piping system
  • 5 is a liquid input end of the reactor
  • 6 is a liquid output end of the reactor
  • 7 is a gas inlet
  • 8 At the inlet end of the piping system
  • 9 is the outlet end of the piping system
  • 10 is a gas filter
  • 11 is a closed sealing cover.
  • FIG. 1 is a schematic structural diagram of a cardiopulmonary perfusion bioreactor device; the present invention discloses a circulating perfusion bioreactor device comprising a bioreactor 1 and a perfusion device 2, the perfusion device 2 comprising a peristaltic pump and being placed in a peristaltic
  • the piping system 4 on the pump, the bioreactor 1 comprises a sterile culture chamber 3 and a closed anastomosis cover 11.
  • the liquid inlet end 5 of the reactor is opened on the side wall of the bioreactor 1, and the liquid inlet end 5 and the gas inlet port 7 of the reactor are opened on the closed anastomosis cover 11.
  • the pipe system 4 is a silicone tube-like structure.
  • the inlet end 8 of the piping system on the silica inflow section is connected to the liquid output end 6 on the reactor, and the outlet end 9 of the piping system on the silica outflow section is connected to the liquid input end 5 on the reactor, the gas A gas filter 10 is connected to the inlet 7, and the liquid input end 5 on the reactor and the liquid output end 6 on the reactor are detachable and independent tubular-like structures, and the closed anastomosis cover 11 and the sterile culture chamber 3 are arranged at an anastomosis.
  • the liquid input end 5 of the reactor is fine at both ends, respectively connected to the silicone tube and the trocar, and the intermediate diameter is increased to exhibit a drip-like structure, and the liquid input end 5 and the reactor side wall of the reactor are arranged.
  • the bioreactor 1 is made of transparent material or disposable sterile material.
  • the transparent material is transparent borosilicate glass or quartz glass, and the pipe system 4 can withstand 120-200 degrees.
  • High-pressure steam-sterilized silicone tube, disposable sterile material is transparent, non-toxic, stable in performance, and does not release toxic substances in cell culture environment.
  • the circulating perfusion bioreactor 1 system disclosed in the present invention simulates blood flow in the body and provides nutrients necessary for long-term culture of cells in the stent. Both the circulating perfusion device 2 and the bioreactor 1 are placed in a carbon dioxide incubator. The liquid output end 6 of the reactor penetrates below the liquid level, and the liquid in the sterile culture chamber 3 is pumped out by the peristaltic pump outside the reactor, through the closed silicone pipe system 4 and the liquid input connected thereto. It flows into the three-dimensional scaffold and then flows out into the sterile culture chamber 3 in the reactor through the outflow port of the three-dimensional scaffold, thereby realizing continuous circulation perfusion culture of the three-dimensional scaffold.
  • the three-dimensional scaffold is a biocompatible material having a liquid inflow port and an outflow port, and the intact vasculature is retained, and the trocar is ligated with the liquid inflow port of the scaffold to form a liquid inlet tube of the three-dimensional scaffold,
  • the liquid inlet pipe is connected to the liquid input end 5 of the reactor, and the liquid outflow port of the three-dimensional support is directly opened to the sterile culture chamber 3.
  • the present invention further clarifies the technical scheme of the present invention by taking a whole liver decellularized scaffold as an example, and performing specific embodiments from two stages of whole liver decellularized scaffold recellularization and in vitro culture:
  • the whole liver decellularization scaffold recellularization stage that is, the cell planting stage.
  • the whole liver decellularized scaffold obtained by the detergent rinsing is placed in a sterile dish, and the seed cells are suspended in 5 ml of the culture solution, and slowly injected into the stent through the portal vein, and the culture is allowed to stand in the incubator for a period of time. Tissue perfusion culture is performed.
  • the circulating perfusion device 2 and the bioreactor 1 are both placed in a carbon dioxide incubator.
  • the whole liver acellular scaffold is cultured in the sterile culture chamber 3 of the bioreactor 1, and the culture medium in the sterile culture chamber 3 enters the closed conduit system 4 through the liquid output end 6 of the reactor deep into the liquid level, under the control of the peristaltic pump
  • the culture solution is subjected to a three-dimensional stent of the whole liver through the liquid input end 5 of the reactor.
  • the culture medium enters the sterile culture chamber 3 after circulating in the whole liver three-dimensional stent, and repeats the above-mentioned circulation process, thereby realizing the completion of the culture solution in the three-dimensional stent. Full cycle.
  • Example 1 Seed cells were cultured in whole liver decellularized scaffolds
  • the portal vein was seen in the middle of the abdomen of the rat, and the trocar was inserted through the portal vein for subsequent continuous perfusion of the detergent to obtain a rat whole liver acellular stent, which retained the intact vessel. Structure, as well as extracellular matrix components.
  • the seed cells were suspended in 5 ml of the culture medium, and were injected into the stent through a trocar connected with a portal vein ligation. The culture was allowed to stand in the culture dish for a period of time, and then the whole liver was perfused and cultured.
  • the culture solution is added to the sterile culture chamber 3 of the bioreactor 1, and the trocar connected to the portal vein on the whole liver stent is connected to the liquid input end 5 of the reactor, wherein the liquid input end 5 of the reactor and the reactor side wall are At an angle of 75°, the liquid outflow port of the whole liver stent is directly opened in the sterile culture chamber 3.
  • the liquid output end 6 of the reactor penetrates into the liquid level in the sterile culture chamber 3, and the inlet end 8 of the piping system on the silica inflow section is connected to the liquid output end 6 of the reactor, and the outlet end of the piping system on the silica gel outlet section is reacted.
  • the liquid inlets 5 are connected to form a closed circulating perfusion bioreactor unit.
  • the gas filter 10 on the closed anastomosis cover 11 ensures that the gas entering the bioreactor 1 is sterile. Under the control of the peristaltic pump, the circulating perfusion of the culture fluid in the whole liver stent is realized, and the supply of oxygen and nutrients of the seed cells in the decellularized stent is ensured. The entire set of circulating perfusion bioreactor 1 is placed in a carbon dioxide incubator.
  • Example 2 Effect of different perfusion rates on seed cells in whole liver stents
  • the portal vein was seen in the middle of the abdomen of the rat, and the trocar was inserted through the portal vein for subsequent continuous perfusion of the detergent to obtain a rat whole liver acellular stent, which retained the intact vessel. Structure, as well as extracellular matrix components.
  • the seed cells were suspended in 5 ml of the culture medium, and were injected into the stent through a trocar connected with a portal vein ligation. The culture was allowed to stand in the culture dish for a period of time, and then the whole liver was perfused and cultured.
  • the culture solution is added to the sterile culture chamber 3 of the bioreactor 1, and the trocar connected to the portal vein on the whole liver stent is connected to the liquid input end 5 of the reactor, wherein the liquid input end 5 of the reactor and the reactor side wall are At an angle of 75°, the liquid outflow port of the whole liver stent is directly opened in the sterile culture chamber 3.
  • the liquid output end 6 of the reactor penetrates into the liquid level in the sterile culture chamber 3, and the inlet end 8 of the piping system on the silica inflow section is connected to the liquid output end 6 of the reactor, and the outlet end of the piping system on the silica gel outlet section is reacted.
  • the liquid inlets 5 are connected to form a closed circulating perfusion bioreactor unit.
  • the gas filter 10 on the closed anastomosis cover 11 ensures that the gas entering the bioreactor 1 is sterile.
  • Continuous perfusion culture at different perfusion rates was performed by adjusting the perfusion rate of the peristaltic pump. After one week of culture, observe and compare different perfusions The effect of speed on seed cells in acellular scaffolds.
  • Example 3 Differentiation and culture of stem cells in acellular scaffold
  • BMSCs Bone marrow mesenchymal stem cells
  • the culture solution is added to the sterile culture chamber 3 of the bioreactor 1, and the trocar connected to the portal vein on the whole liver stent is connected to the liquid input end 5 of the reactor, wherein the liquid input end 5 of the reactor and the reactor side wall are At an angle of 75°, the liquid outflow port of the whole liver stent is directly opened in the sterile culture chamber 3.
  • the liquid output end 6 of the reactor penetrates into the liquid level in the sterile culture chamber 3, and the inlet end 8 of the piping system on the silica inflow section is connected to the liquid output end 6 of the reactor, and the outlet end of the piping system on the silica gel outlet section is reacted.
  • the liquid inlets 5 are connected to form a closed circulating perfusion bioreactor unit.
  • the gas filter 10 on the closed anastomosis cover 11 ensures that the gas entering the bioreactor 1 is sterile. Under the control of the peristaltic pump, the circulating perfusion of the culture fluid in the whole liver stent is realized, and the supply of oxygen and nutrients of the seed cells in the decellularized stent is ensured.
  • the cells were cultured for 2 days in serum-free IMDM medium, followed by hepatic differentiation culture of whole liver decellularized stem cells, collected at 3 days, 1, 2, and 3 weeks after circulating culture. Tissue and culture supernatant were analyzed to identify the differentiation effect of stem cells in decellularized scaffolds, and the effect of decellularized scaffolds on stem cell differentiation was evaluated.
  • the bioreactor of the invention is simple and convenient to operate, and can provide the cardiomyocytes in the whole liver decellularization scaffold with a continuous simulated physiological condition of the extracorporeal circulation, providing sufficient gas and nutrients for the seed cell growth, and recellularizing the decellularized scaffold.

Abstract

L'invention concerne un dispositif de bioréacteur à perfusion à recirculation comprenant un bioréacteur et un dispositif de perfusion ; le dispositif de perfusion comprend une pompe péristaltique et un système de conduit installé sur la pompe péristaltique, le bioréacteur comprend une chambre de culture stérile et un bouchon d'adaptation étanche à l'air ; et un échafaudage tridimensionnel peut être relié à l'intérieur du bioréacteur.
PCT/CN2016/075779 2016-03-07 2016-03-07 Dispositif de bioréacteur à perfusion à recirculation capable d'effectuer une perfusion à recirculation d'un échafaudage tridimensionnel WO2017152343A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201610125231 2016-03-07
CN201610125231.4 2016-03-07

Publications (1)

Publication Number Publication Date
WO2017152343A1 true WO2017152343A1 (fr) 2017-09-14

Family

ID=59789015

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2016/075779 WO2017152343A1 (fr) 2016-03-07 2016-03-07 Dispositif de bioréacteur à perfusion à recirculation capable d'effectuer une perfusion à recirculation d'un échafaudage tridimensionnel

Country Status (1)

Country Link
WO (1) WO2017152343A1 (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111304078A (zh) * 2018-12-11 2020-06-19 上海市第五人民医院 模拟脑脊液生物力学环境构建组织工程骨组织的装置及其方法
CN111849749A (zh) * 2020-03-31 2020-10-30 同济大学 一种成年小动物心肌细胞高效分离系统
CN112430540A (zh) * 2020-10-21 2021-03-02 英诺维尔智能科技（苏州）有限公司 一种可置于生物培养箱内的紧凑型反应器
CN113025491A (zh) * 2021-03-17 2021-06-25 杭州电子科技大学 一种细胞在体外动态培养用灌流式反应器

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998020106A1 (fr) * 1996-11-01 1998-05-14 Genespan Corporation Incubateur pour culture cellulaire
EP1063289A1 (fr) * 1998-03-03 2000-12-27 JMS Co., Ltd. Clones céllulaires du foie pour foie artificiel et dispositif d'assistance hépatique extracorporel
CN2738750Y (zh) * 2003-12-22 2005-11-09 冯滨 一种心脏组织工程瓣膜脉动流培养装置
CN102296029A (zh) * 2010-06-28 2011-12-28 裴国献 灌注式生物反应器系统
CN104611225A (zh) * 2015-02-16 2015-05-13 昆明市第一人民医院 体外循环灌流构建组织工程肝的生物反应器

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998020106A1 (fr) * 1996-11-01 1998-05-14 Genespan Corporation Incubateur pour culture cellulaire
EP1063289A1 (fr) * 1998-03-03 2000-12-27 JMS Co., Ltd. Clones céllulaires du foie pour foie artificiel et dispositif d'assistance hépatique extracorporel
CN2738750Y (zh) * 2003-12-22 2005-11-09 冯滨 一种心脏组织工程瓣膜脉动流培养装置
CN102296029A (zh) * 2010-06-28 2011-12-28 裴国献 灌注式生物反应器系统
CN104611225A (zh) * 2015-02-16 2015-05-13 昆明市第一人民医院 体外循环灌流构建组织工程肝的生物反应器

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111304078A (zh) * 2018-12-11 2020-06-19 上海市第五人民医院 模拟脑脊液生物力学环境构建组织工程骨组织的装置及其方法
CN111304078B (zh) * 2018-12-11 2023-12-08 上海市第五人民医院 模拟脑脊液生物力学环境构建组织工程骨组织的装置及其方法
CN111849749A (zh) * 2020-03-31 2020-10-30 同济大学 一种成年小动物心肌细胞高效分离系统
CN111849749B (zh) * 2020-03-31 2022-02-18 同济大学 一种成年小动物心肌细胞高效分离系统
CN112430540A (zh) * 2020-10-21 2021-03-02 英诺维尔智能科技（苏州）有限公司 一种可置于生物培养箱内的紧凑型反应器
CN113025491A (zh) * 2021-03-17 2021-06-25 杭州电子科技大学 一种细胞在体外动态培养用灌流式反应器

Similar Documents

Publication Publication Date Title
CN105586249B (zh) 一种可实现三维支架循环灌流的循环灌流生物反应器装置
Sodian et al. Tissue-engineering bioreactors: a new combined cell-seeding and perfusion system for vascular tissue engineering
Chen et al. Bioreactors for tissue engineering
WO2017152343A1 (fr) Dispositif de bioréacteur à perfusion à recirculation capable d'effectuer une perfusion à recirculation d'un échafaudage tridimensionnel
CN106232801A (zh) 自动化细胞培养和收获装置
CN104611225A (zh) 体外循环灌流构建组织工程肝的生物反应器
US11773362B2 (en) Modular bioreactor, compliance chamber for a bioreactor, and cell seeding apparatus
US8735143B2 (en) Hepatic lobule-like bioreactor
CN204779609U (zh) 体外循环灌流构建组织工程肝的生物反应器
ES2733318T3 (es) Biorreactor para ingeniería de tejidos
CN105505775A (zh) 一种体外肝支持系统
CN105087380A (zh) 大规模培养动物细胞的系统
CN103966092A (zh) 器官脱细胞循环灌流再生培养瓶
JP2008092935A (ja) 密封培養容器にポンプ機能を設けた培養装置
CN102154101A (zh) 成骨性种子细胞一体化动态接种培养及配套生物反应器
WO2016140213A1 (fr) Procédé de culture cellulaire mettant en œuvre un module à fibres creuses
IT201800007946A1 (it) Modello per simulare in-vitro il comportamento di vasi disfunzionali
Dermenoudis et al. Bioreactors in tissue engineering
Visconti et al. Cardiovascular tissue engineering I. Perfusion bioreactors: a review
JP2007075090A (ja) 旋回培養装置
Lyons et al. Design of bioreactors for cardiovascular applications
CN205241705U (zh) 一种组织工程软骨体外培养装置
CN203564380U (zh) 一种体内生物反应器
CN211035948U (zh) 一种模块化三维灌注细胞培养系统
CN108085254A (zh) 组织工程产品培养装置

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 16892995

Country of ref document: EP

Kind code of ref document: A1

122 Ep: pct application non-entry in european phase

Ref document number: 16892995

Country of ref document: EP

Kind code of ref document: A1